Camlin Fine Sciences Ltd 09 Nov 2026 12:00 AM
Camlin Fine Sciences promoter pledged shares to SKS Fincap and Ashika Global Securities,
Ashish S. Dandekar, a promoter of Camlin Fine Sciences Limited, has pledged 1,63,10,000 shares, representing 8.49% of the company`s total share capital, on November 6, 2026, to SKS Fincap Private Limited and Ashika Global Securities Limited (formerly Ashika Credit Capital Limited) for an additional margin pledge to cover a shortfall in security cover related to financial assistance obtained by Camlin Fine Sciences Limited. Dandekar`s total holding in Camlin Fine Sciences Limited is 1,97,78,510 shares, constituting 10.30% of the total share capital.
Camlin Fine Sciences Ltd 09 Nov 2026 12:00 AM
Camlin Fine Sciences promoter pledged over 19.7 million shares to SKS Fincap and Ashika Global,
Ashish Subhash Dandekar, a promoter of Camlin Fine Sciences Limited, has pledged 1,97,78,510 shares, representing 10.30% of the company`s total share capital, to SKS Fincap Private Limited and Ashika Global Securities Limited (formerly Ashika Credit Capital Limited) on November 6, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The pledge, totaling 2,90,000 shares and 7,90,000 shares respectively, was created as an additional margin pledge to cover a shortfall in security cover related to financial assistance obtained by Camlin Fine Sciences Limited.
Camlin Fine Sciences Ltd 05 Nov 2026 12:00 AM
Camlin Fine Sciences Ltd consolidated sales down 5.46% on year in Q3FY2026, net profit dropped 11.66%,
Camlin Fine Sciences Ltd share price plunged by 18.65% to Rs 74.13 after the company`s net profit fell 11.66% to Rs 29.7 crore, while revenue from operations slipped slightly by 5.46% to Rs 491.47 crore in Q3FY26 over Q2FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.72 lakh crore, easing 8.63%. It has improved by 2.66% over last one week and dipped slightly by 6.33% in last one month while the market capitalization of Camlin Fine Sciences Ltd has softened by 9.98% and 41.38% in the same period respectively. Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 36.51 crore in Q3 FY26, surging by 302.98% year-on-year, and gaining 7.10% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 108.70% YoY and plunging by 134.38% sequentially. Total expenses eased by 3.89% to Rs 509.15 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 264.2 crore, declining 15.42% YoY, while employee benefits expense was at Rs 72.27 crore, softening 1.58% YoY. For the TTM ended FY26, revenue from operations inched higher 5.81% to Rs 1723.31 crore, while net profit tanked by 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA surged by 20985% to Rs 78.09 crore, and PBT collapsed by 149.54% to Rs 31.99 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25. Camlin Fine Sciences Ltd tumbled by 62.26% in last one year, underperforming the benchmark BSE Sensex which has slipped by 7.38% during the same period.
Camlin Fine Sciences Ltd 04 Nov 2026 12:00 AM
Camlin Fine Sciences Ltd consolidated sales down 5.46% on year in Q3FY2026, net profit contracted by 11.66%,
Camlin Fine Sciences Ltd share price gained 2.86% to Rs 91.12. The Company`s net profit fell 11.66% to Rs 29.7 crore, while revenue from operations eased by 5.46% to Rs 491.47 crore in Q3FY26 over Q2FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.76 lakh crore, rising by 13.35%. It has improved by 2.10% over last one week and dipped slightly by 7.82% in last one month while the market capitalization of Camlin Fine Sciences Ltd has inched up 8.48% and 28.73% in the same period respectively. Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 36.51 crore in Q3 FY26, surging by 302.98% year-on-year, and easing 7.10% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 108.70% YoY and plunging by 134.38% sequentially. Total expenses marginally dropped 3.89% to Rs 509.15 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 264.2 crore, falling by 15.42% YoY, while employee benefits expense was at Rs 72.27 crore, dipping slightly 1.58% YoY. For the TTM ended FY26, revenue from operations grew marginally by 5.81% to Rs 1723.31 crore, while net profit witnessed a sharp fall of 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA soared by 20985% to Rs 78.09 crore, and PBT tanked by 149.54% to Rs 31.99 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25. Camlin Fine Sciences Ltd tumbled by 54.38% in last one year, underperforming the benchmark BSE Sensex which has eased by 8.41% during the same period.
Camlin Fine Sciences Ltd 03 Nov 2026 12:00 AM
Camlin Fine Sciences Ltd consolidated sales down 5.46% on year in Q3FY2026, net profit fell 11.66%,
Camlin Fine Sciences Ltd share price advanced by 5.40% to Rs 88.59. The Company`s net profit contracted by 11.66% to Rs 29.7 crore, while revenue from operations eased by 5.46% to Rs 491.47 crore in Q3FY26 over Q2FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.64 lakh crore, rising by 13.18%. It has marginally improved by 0.04% over last one week and eased lower by 7.04% in last one month while the market capitalization of Camlin Fine Sciences Ltd has inched up 5.64% and 31.67% in the same period respectively. Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 36.51 crore in Q3 FY26, expanding by 302.98% year-on-year, and rising 7.10% quarter-on-quarter. EBITDA came in at Rs 3 crore, tumbling by 108.70% YoY and plunging by 134.38% sequentially. Total expenses slightly declined by 3.89% to Rs 509.15 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 264.2 crore, contracting by 15.42% YoY, while employee benefits expense was at Rs 72.27 crore, registering a marginal contraction of 1.58% YoY. For the TTM ended FY26, revenue from operations inched higher 5.81% to Rs 1723.31 crore, while net profit tumbled by 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA surged by 20985% to Rs 78.09 crore, and PBT plunged by 149.54% to Rs 31.99 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25. Camlin Fine Sciences Ltd nosedived by 55.65% in last one year, underperforming the benchmark BSE Sensex which has softened by 9.87% during the same period.
Subscribe for our
newsletter
Open Account Now